Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 59,000 CTMX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 59,000 | n/a |
| Jun 22, 2026 | NextCure, Inc. (NXTC) | Grant/Award | 2,340 | n/a |
| Jun 24, 2025 | NextCure, Inc. (NXTC) | Grant/Award | 18,700 | n/a |
| Jun 13, 2025 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 38,000 | n/a |
| Jun 21, 2024 | NextCure, Inc. (NXTC) | Grant/Award | 18,700 | n/a |
| Jun 20, 2024 | Gritstone bio, Inc. (GRTS) | Grant/Award | 51,800 | n/a |
| May 17, 2024 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 38,000 | n/a |
| Jun 23, 2023 | NextCure, Inc. (NXTC) | Grant/Award | 14,250 | n/a |
| Jun 16, 2023 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 25,000 | n/a |
| Mar 31, 2023 | CytomX Therapeutics, Inc. (CTMX) | Purchase | 5,000 | $7.8K |